Cargando…
Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
Mycophenolate mofetil (MMF) as an immunosuppressive agent is used to prevent graft rejection. One of the adverse effects of long time administration of MMF is the gastrointestinal disorder. This study aimed to investigate the gastroprotective effect of silymarin (SMN) on MMF-induced gastrointestinal...
Autores principales: | Sheikhzadeh, Sanaz, Malekinejad, Hassan, Hobbenaghi, Rahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Urmia University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313006/ https://www.ncbi.nlm.nih.gov/pubmed/25653776 |
Ejemplares similares
-
Silymarin attenuates mycophenolate mofetil-induced duodenal disorders in rats
por: Malekinejad, Hassan, et al.
Publicado: (2014) -
Fructooligosaccharide raftilose reduces the mycophenolate mofetil-induced complications: Hematological and biochemical alterations
por: Cheraghi, Hadi, et al.
Publicado: (2015) -
Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis
por: Malekinejad, H., et al.
Publicado: (2012) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022) -
Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)